StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30956% above fair value
$55.39+1.28 (+2.37%)

Close on Nov 20, 2026Market cap $2.82BP/E 263.8Yield –

AtriCure gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

AtriCure's gross profit for the twelve months ending Jun 30, 2026 was $434.61M, up 16.4% year over year. For fiscal 2025 it was $400.78M, up 15.3% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is $400.78M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$400.78M+15.3%
FY2024Dec 31, 2024$347.52M+15.7%
FY2023Dec 31, 2023$300.37M+22.1%
FY2022Dec 31, 2022$245.94M+19.5%
FY2021Dec 31, 2021$205.86M+37.9%
FY2020Dec 31, 2020$149.31M-12.3%
FY2019Dec 31, 2019$170.34M+15.8%
FY2018Dec 31, 2018$147.12M+16.6%
FY2017Dec 31, 2017$126.16M+13.6%
FY2016Dec 31, 2016$111.10M+19.6%
FY2015Dec 31, 2015$92.88M+22.6%
FY2014Dec 31, 2014$75.75M+27.2%
FY2013Dec 31, 2013$59.56M+19.1%
FY2012Dec 31, 2012$50.01M+6.4%
FY2011Dec 31, 2011$47.00M+3.5%
FY2010Dec 31, 2010$45.39M+8.6%
FY2009Dec 31, 2009$41.78M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$118.63M+16.9%
Q1 FY2026Mar 31, 2026$109.31M+18.0%
Q4 FY2025Dec 31, 2025$105.34M+13.7%
Q3 FY2025Sep 30, 2025$101.33M+16.8%
Q2 FY2025Jun 30, 2025$101.48M+16.9%
Q1 FY2025Mar 31, 2025$92.63M+14.0%
Q4 FY2024Dec 31, 2024$92.62M+16.0%
Q3 FY2024Sep 30, 2024$86.79M+17.5%
Q2 FY2024Jun 30, 2024$86.84M+12.7%
Q1 FY2024Mar 31, 2024$81.27M+16.7%
Q4 FY2023Dec 31, 2023$79.82M+22.6%
Q3 FY2023Sep 30, 2023$73.87M+19.7%
Q2 FY2023Jun 30, 2023$77.08M+21.3%
Q1 FY2023Mar 31, 2023$69.61M+25.2%
Q4 FY2022Dec 31, 2022$65.11M+18.4%
Q3 FY2022Sep 30, 2022$61.71M+18.2%
Q2 FY2022Jun 30, 2022$63.52M+17.5%
Q1 FY2022Mar 31, 2022$55.60M+24.8%
Q4 FY2021Dec 31, 2021$55.02M+29.6%
Q3 FY2021Sep 30, 2021$52.23M+29.5%
Q2 FY2021Jun 30, 2021$54.08M+95.6%
Q1 FY2021Mar 31, 2021$44.54M+14.5%
Q4 FY2020Dec 31, 2020$42.44M-5.2%
Q3 FY2020Sep 30, 2020$40.33M-3.5%
Q2 FY2020Jun 30, 2020$27.65M-37.0%
Q1 FY2020Mar 31, 2020$38.88M-2.5%
Q4 FY2019Dec 31, 2019$44.77M+16.0%
Q3 FY2019Sep 30, 2019$41.80M+16.3%
Q2 FY2019Jun 30, 2019$43.89M+15.3%
Q1 FY2019Mar 31, 2019$39.87M+15.6%
Q4 FY2018Dec 31, 2018$38.59M+18.1%
Q3 FY2018Sep 30, 2018$35.95M+16.3%
Q2 FY2018Jun 30, 2018$38.08M+17.0%
Q1 FY2018Mar 31, 2018$34.50M+15.0%
Q4 FY2017Dec 31, 2017$32.68M+13.1%
Q3 FY2017Sep 30, 2017$30.92M+12.5%
Q2 FY2017Jun 30, 2017$32.55M–
Q1 FY2017Mar 31, 2017$30.01M–
Q4 FY2016Dec 31, 2016$28.90M–
Q3 FY2016Sep 30, 2016$27.47M–

More AtriCure figures

See a number that looks wrong?